The intersection between healthcare, technology, strategy and impact – Interview with Ochre Bio’s CEO and co-founder Jack O’Meara

Published on July 24, 2023

Today, we had the pleasure to interview Jack O’Meara, CEO and co-founder of Ochre Bio, a pioneering biotechnology company based in Oxford. Since its foundation in 2019, they have been able to secure over €35 million to develop RNA therapies for chronic liver diseases using a combination of genomic deep phenotyping, precision RNA medicine, and…

This content is for members only. Visit the site and log in/register to read.

The post The intersection between healthcare, technology, strategy and impact – Interview with Ochre Bio’s CEO and co-founder Jack O’Meara appeared first on EU-Startups.